- Home
- OUSTZ vs ADXN Comparison
OUSTZ vs ADXN Comparison
Compare OUSTZ & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUSTZ
- ADXN
- Stock Information
- Founded
- OUSTZ N/A
- ADXN 2002
- Country
- OUSTZ United States
- ADXN Switzerland
- Employees
- OUSTZ 290
- ADXN N/A
- Industry
- OUSTZ Industrial Machinery/Components
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- OUSTZ Industrials
- ADXN Health Care
- Exchange
- OUSTZ Nasdaq
- ADXN Nasdaq
- Market Cap
- OUSTZ N/A
- ADXN 8.0M
- IPO Year
- OUSTZ N/A
- ADXN N/A
- Fundamental
- Price
- OUSTZ $0.08
- ADXN $8.04
- Analyst Decision
- OUSTZ
- ADXN Strong Buy
- Analyst Count
- OUSTZ 0
- ADXN 1
- Target Price
- OUSTZ N/A
- ADXN $30.00
- AVG Volume (30 Days)
- OUSTZ N/A
- ADXN 31.7K
- Earning Date
- OUSTZ N/A
- ADXN 03-24-2025
- Dividend Yield
- OUSTZ N/A
- ADXN N/A
- EPS Growth
- OUSTZ N/A
- ADXN N/A
- EPS
- OUSTZ N/A
- ADXN 0.06
- Revenue
- OUSTZ N/A
- ADXN $701,260.00
- Revenue This Year
- OUSTZ N/A
- ADXN N/A
- Revenue Next Year
- OUSTZ N/A
- ADXN N/A
- P/E Ratio
- OUSTZ N/A
- ADXN $1.00
- Revenue Growth
- OUSTZ N/A
- ADXN N/A
- 52 Week Low
- OUSTZ N/A
- ADXN $6.81
- 52 Week High
- OUSTZ N/A
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- OUSTZ N/A
- ADXN 43.93
- Support Level
- OUSTZ N/A
- ADXN $6.81
- Resistance Level
- OUSTZ N/A
- ADXN $7.98
- Average True Range (ATR)
- OUSTZ 0.00
- ADXN 0.56
- MACD
- OUSTZ 0.00
- ADXN -0.03
- Stochastic Oscillator
- OUSTZ 0.00
- ADXN 25.69
About OUSTZ Ouster Inc. Warrants
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.